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2Abstract
Purpose: To assess the feasibility of a hybrid ablative technique based on applying
electroporation (EP) pulses just before conducting radiofrequency ablation (RFA). The
rationale was that the EP-induced reduction in blood perfusion could be sufficient to
reduce the thermal sink effect and hence to increase the coagulation volume in
comparison to that created exclusively by RFA.
Materials and methods: Modeling study and in vivo experimental study. A Cool-tip RF
applicator was used both for EP and RFA.
Results: Overall, the results did not show any synergy effect from using the hybrid
technique. Applying EP pulses prior to RFA did not increase the coagulation zone
obtained and the lesions were almost identical. Additional computer simulations
provided an explanation for this; the effect of reducing blood perfusion by thermal
damage during RFA completely masks the effect of reducing blood perfusion by EP.
This is because both thermal damage and EP affect the same zone, i.e. the tissue around
the electrode.
Conclusions: Our computer modeling and in vivo experimental findings suggest that the
combination of EP and RFA with monopolar applicators does not provide an additional
benefit over the use of RFA alone.
Keywords: Electroporation, radiofrequency ablation
Running head: Electroporation before RF ablation
3Introduction
Radiofrequency (RF) ablation (RFA) is a minimally invasive ablative technique used to
treat certain tumors [1, 2] by using RF current (≈500 kHz) to produce a coagulation 
zone characterized by a thermal lesion which destroys the target tissue by necrosis. The
coagulation zone is defined as the zone containing irreversibly damaged tissue, i.e. with
temperatures above 50ºC [3]. In order to treat large tumors, therefore, the RF applicator
should be able to create large coagulation zones. One of the most important factors
limiting coagulation zone size is blood perfusion through the capillaries, which causes a
thermal sink effect [4]. In fact, the coagulation zone can be increased during RFA when
blood flow is reduced by clamping the organ’s main artery [5]. Unfortunately, this
maneuver produces a generalized ischemia in the organ and hence is not a satisfactory
solution.
In Electroporation (EP) cell membrane permeability to ions and macromolecules is
increased after exposing the cell to high electric field short pulses. According to the
number of pulses, their magnitude, duration and other factors, the permeability will be
either temporary and will not compromise cell viability (i.e. "reversible
electroporation") or will be permanent, or too intense, so that cell homeostasis will be
severely disrupted and the cell will end up dying by necrotic or apoptotic processes (i.e.
"irreversible electroporation"). Both reversible and irreversible EP modes have
important applications in biotechnology and medicine. For instance, reversible EP is
now a routine technique in microbiology labs for in vitro gene transfection. During the
last fifteen years, reversible electroporation has been applied experimentally and
clinically to living tissues for in vivo gene therapy (electrogenetherapy) and for
enhancing the penetration of anti-cancer drugs into cancer cells (electrochemotherapy)
[6]. More recently, irreversible EP has been proposed and demonstrated as a minimally
4invasive tissue ablation method [7].
An interesting outcome of performing EP in living tissues is the immediate local
reduction in blood flow. Blood perfusion has been reduced by about 70% for example in
subcutaneous tumors a few seconds after receiving eight 100 μs pulses at a magnitude 
of 130000 V/m and a repetition rate of 1 Hz [8]. This reduction is related to
microvascular occlusion of capillaries and arterioles and in some cases reverts in a
matter of minutes or hours [9, 10]. Two main explanations have been hypothesized for
this phenomenon: 1) a sympathetically mediated constriction of smooth vascular
musculature would explain the first rapid phase of blood flow reduction and 2) damage
to the endothelial monolayer by electroporation would cause liquid extravasation, which
would increase parenchyma pressure, collapse vessels and thus cause blood occlusion
[8].
With these results in mind, we hypothesized that the reduced blood perfusion caused
by EP pulses applied prior to RFA could be sufficient to reduce the thermal sink effect,
and hence to increase coagulation volume more than that created solely by RFA. In
order to assess the feasibility of this hybrid ablative technique, we first planned a
theoretical modeling study in which a Cool-tip RF applicator was used to apply both EP
pulses and RF power to hepatic tissue. We then conducted an experimental study based
on an in vivo model to validate the theoretical results obtained.
Materials and methods
Theoretical modeling: General characteristics
The theoretical model was based on a coupled EP+RF problem, each part of which was,
in turn, based on a coupled electric-thermal problem and solved numerically using the
Finite Element Method (FEM) by means of COMSOL Multiphysics 3.5a (COMSOL,
5Burlington, MA, USA). The geometry and dimensions of the theoretical model are
shown in Fig. 1. The problem presented axial symmetry, so that a 2D analysis could be
conducted. The model included three different materials: plastic partially covering the
electrode, a metallic electrode, and hepatic tissue. The values of the characteristics of
these materials are given in Table I [11-14]. It should be noted that the electrical
conductivity value for hepatic tissue corresponds to the RF problem; the conductivity
value for the EP problem is somewhat lower (see the following subsection). The
dispersive electrode was modeled as an electrical condition on boundaries at a distance
from the active electrode.
Theoretical model: EP problem
As described below in the RF problem, the electric field in the tissue due to an EP pulse
was computed by means of the FEM tool. The Quasi-Statics/Electric application mode
of the AC/DC Module of COMSOL was employed to obtain the electric field when a
pulse of 2000 V was applied between the active electrode and dispersive electrode (Fig.
1).
Non-linear resistive behavior was assumed for the hepatic tissue (Gompertz sigmoid
expression, Eq. 1) to model the increase in tissue electrical conductivity during pulse
delivery due to EP [15]. It has recently been shown that modeling this effect
significantly improves the accuracy of these simulations [16,17]. DC conductivity at
low electric field magnitudes (σ0 = 0.08 S/m) and DC conductivity at very high fields
(σMAX = 0.31 S/m = σ0 + Δσ) were obtained from [15]. The sigmoid behavior and the
parameters that determine its shape were adjusted from data in [18]. Gompertz sigmoid
function was chosen instead of other possible sigmoid functions, such as the sigmoid
6expression employed in [18], because its shape parameters are easily identifiable in the
expression.
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The simulated time was not relevant, since no time-dependant properties or effects
were modeled. Nevertheless, for the sake of conceptual consistency, the electric field
for computing perfusion was recorded at the end of a pulse of 100 μs. This pulse 
included a rise ramp of 5 μs to facilitate the convergence of the solution required by the 
iterative process, in which the electric field distribution depends on the conductivity of
the previous step and vice versa.
Prior to the RF problem, the computed electric field magnitude at the end of the
100 μs was scaled according to the following expression (2) to obtain the reduction in 
blood flow:
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where α represents the relative blood perfusion level; 1 indicates the normal perfusion
level (i.e. before EP or in tissue zones in which the electric field magnitude is
insufficient to cause any blood flow disturbance) and 0 represents the complete
disruption of blood flow. Note that a linear decrease in blood perfusion was modeled
between two electric field values (75000 V/m and 130000 V/m) and that the minimum
relative blood perfusion level achievable by EP is 0.3.
The above blood perfusion expression was obtained by approximation of data in [8],
which corresponds to experimental measurements in subcutaneous tumors after a
7sequence of eight 100 μs pulses. These original data together with the function used to 
model them (α) are depicted in Figure 2.
Quantitative liver data is not presently available, but as similar quantitative data was
obtained for skeletal muscle [19] and qualitative observations on liver also indicate a
drastic blood perfusion reduction in equivalent conditions [9], this suggests that the
above-described model is sufficiently accurate for the purposes of this study.
Theoretical model: RF problem
The governing equation for the thermal problem was the Pennes Bioheat equation [20].
To incorporate the phase change [21-22] into this equation we used the enthalpy method
[23]:
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where  was density of tissue, h enthalpy, T temperature, t time, k thermal conductivity,
q heat source produced by RF power, Qm the metabolic heat generation (not considered
in RF ablation) and Qp was heat loss from blood perfusion.
For biological tissues, enthalpy is related to tissue temperature by the following
expression [24]:
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where i and ci were tissue density and specific heat of normal tissue (i=l) and the post-
phase-change tissue (i=g), respectively, hfg was the product of water latent heat of
vaporization and water density at 100ºC and C was tissue water content inside the liver
(68%) [25].
8The heat source by RF power q (Joule losses) was given by q=JE, where J is current
density and E is electric field strength. Both were obtained from the electrical problem,
in which we used the Laplace equation 2V=0 as governing equation, V being the
voltage. The electric field was calculated by means of E = V and J using Ohm’s law
(J= E), where is the electrical conductivity. We used a quasi-static approach, i.e. the
tissues were considered as purely resistive [26] due to the value of the frequencies used
in RF (≈500 kHz) and for the geometric area of interest (electrical power is deposited in 
a very small zone close the electrode). We considered temperature-dependent functions
for the electrical and thermal conductivity, and k [26]:  grew exponentially +1.5%/ºC
up to 100ºC [21], between 99 and 100ºC was kept constant and then decreased
linearly 4 orders for five degrees (i.e. up to 105ºC) [23,27]. For k we considered linear
growth of 0.0015/ºC up to 100ºC, after which k was kept constant [23]. The term Qp was
obtained from:
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where b was density of blood (1000 kg/m3) [28], cb specific heat of blood (4180
J/Kg·K) [27], Tb blood temperature (37 ºC), b blood perfusion coefficient (6.410-3 s-1)
[28],  relative blood perfusion which varied between 0 and 1 obtained in the EP
problem, and  was a coefficient which took the values of 0 and 1, depending on the
value of the local thermal damage : = 0 for   1, and = 1 for  < 1[29].  was
assessed by the Arrhenius damage model [30], which associates temperature with
exposure time using a first-order kinetics relationship:
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9where R was the universal gas constant, A was a frequency factor and E was the
activation energy for the irreversible damage reaction. The parameters A and E were
dependent on tissue type; for liver we used those proposed by Jacques et al [31]: A =
7.391039 s-1 and ΔE = 2.577105 J/mol). We employed two thermal damage contours
to compute the lesion dimension contours, which correspond to a damage integral (Ω) 
of 1 and 4.6 (63% and 99% probability of cell death respectively) [29].
Electrical boundary conditions were: zero current density in the transverse direction
to the symmetry axis and inside the electrode. Zero voltage was set in the dispersive
electrode. A voltage of 80 V was applied in the active electrode. Thermal boundary
conditions were: Null thermal flux in the transversal direction to the symmetry axis and
constant temperature of 37ºC in the dispersive electrode. Initial temperature of the tissue
was considered to be 37ºC. The liquid circulating inside the electrode produced a
cooling effect modeled by means of a thermal convection coefficient h with a value of
6,668 W/K∙m2 and a coolant temperature of 10ºC. The value of h was calculated by
considering a length of 30 mm and a flow rate of 45 mL/min through an area of
3.9310-7 m2, which is equivalent to half of the cross section of the inner diameter of the
electrode (see Fig. 1).
The mesh used was heterogeneous, with a finer mesh size at the electrode-tissue
interface, where the highest gradient was expected. The size of the finer mesh was
estimated by a convergence test. We used the value of the maximum temperature (Tmax)
reached in the liver at roll-off time (at which tissue impedance was 30 higher than
the initial [13]) as a control parameter in these analyses. When there was a difference of
less than 0.5% in the control parameter between simulations, we considered the former
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mesh size as appropriate. Analogously, we used a value of 1 for the time-step obtained
from a similar convergence test scheme.
A pulsed RF protocol was used for energy delivery, consisting of the application of
80 V up to roll-off time, after which energy was not applied for 15 s and then 80 V was
again applied until the next roll-off. This protocol was followed for 12 minutes and
implemented by the connection between COMSOL and MATLAB.
Experimental setting
A total of 12 procedures (one in each hepatic lobe) were performed on the liver of three
female Landrace pig under general anesthesia through midline laparotomy. The
procedure was approved by the Ethical Commission of the Universitat Autònoma de
Barcelona (Authorization Number DAAM 6267 and CEEAH 1256). In each animal, in
the first lobe RFA only was performed, in the second an EP protocol only and in the
third and fourth the EP+RF procedure was applied. RFA was conducted immediately
after EP. In both EP and RFA a single Cool-tip applicator with 3 cm-long electrode
(Valleylab, Boulder, CO, USA) was applied parallel to the suprahepatic main vein of
each lobe.
EP pulses were applied in a monopolar arrangement between the Cool-tip applicator
electrode and a single dispersive electrode positioned on the interscapular area. A
custom-made generator was used to deliver 8 square-wave pulses with duration of 100
µs and a magnitude of 2000 V at a repetition frequency of 1 Hz. A high voltage probe
(P5100, Tektronix) and a clamp-on current probe (A622, Tektronix) were used in
combination with a digital oscilloscope (DS01014A, Agilent) to measure voltage and
current signals respectively, to ensure proper application of the pulses.
RFA was also conducted in a monopolar mode between the applicator and the
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dispersive electrode, but in this case the electrode was internally cooled by a Watson
Marlow peristaltic pump (Wilmington, MA, USA), which delivered 0ºC saline at 20
mL/min, beginning 2 minutes prior to RF power deposition. RF power was applied with
a CC-3 generator (Radionics, Burlington, MA, USA) using a pulsed algorithm based on
an impedance control mode for 12 minutes, as employed in clinical use. In each animal,
when the four ablations were complete the animal was euthanized using an IV dose of
sodium pentobarbital. In any case more than one hour elapsed from any thermal injury
to euthanasia.
We immediately conducted a macroscopic assessment of the coagulations as follows:
the liver was cut into 1 cm slices perpendicular to the applicator axis in order to measure
macroscopically maximum and minimum diameters of the coagulation zone. All the
measurements were based on the central “white zone” induced by thermal therapies,
avoiding the red area of hyperemia [32]. Mean values of maximum and minimum
diameters were compared through the groups using the U-Mann-Whitney’s test.
Differences in variables were considered to be significant at a threshold of p<0.05.
Statistical analyses were performed with statistical software (version 19.0, SPSS,
Chicago, IL, USA).
Results
Numerical results
As a result of the EP pulse application the tissue perfusion changed according to the
relative blood perfusion level (). Figure 3 shows the electric field distribution joint
with the resulting blood perfusion at the end of the EP pulse. In the RF problem we first
simulated two cases and then compared their results: the EP+RF procedure (Case 1) and
RFA alone (Case 2). Fig. 4A and 4B show voltage and impedance evolution for the
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Case 1. The EP pulse application interval (7 seconds) is insignificant compared to the
12-minute interval in RFA, and hence the EP period is not plotted. The first roll-off
(sudden impedance rise) was reached at 60 s. The subsequent roll-off were observed 30
s later and the time between roll-offs was decreasing linearly to the fourth roll-off when
the subsequent roll-offs were reached more or less periodically with an interval of  23
s. Note that after every roll-off there was a 15 s period in which almost no voltage was
applied. Fig. 5 shows the 2D temperature distributions and the thermal damage contour
(=1 and =4.6, black lines) at the end of RFA (12 minutes) in Case 1. In Table II are
shown the transverse diameter of the thermal lesion for both thermal damage contours.
The maximum temperature reached in the tissue was 110ºC. In Figure 6 we observed
the temperature distribution in case 1 at the end of the RF application (12 minutes) and
the contour lines corresponding to the blood perfusion level () obtained from the EP
problem.
The theoretical results from RFA-alone (Case 2) were extremely similar to the
EP+RF case. The first roll-off occurred at 61 s, and the following roll-offs were
observed with a similar periodicity than in case 1. Fig. 4C shows the impedance
evolution for the RFA-alone case. Note that in Figs. 4B and 4C the roll-off episodes
occur almost at the same time. Likewise, the temperature distributions (not shown) were
almost identical to the EP+RF case, with similar values for the minor diameter of the
lesion (see Table II).
Since the computer results from both cases were almost identical, we planned
additional computer simulations in order to provide a possible explanation. We
hypothesized that the dependence of blood perfusion on thermal damage (term  in Eq.
5) could drastically reduce the impact of EP on the perfusion term ( in Eq. 5), specially
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when the EP effect is confined exclusively to the tissue adjacent to the electrode. To
confirm this hypothesis we simulated two additional cases: EP+RF with the blood
perfusion term independent of thermal damage (Case 3) and also RFA alone with
perfusion independent of thermal damage (Case 4). The results from these two
additional cases were found to be different to Cases 1 and 2. While the first roll-offs
occurred at 68 s and 74 s in Cases 3 and 4, respectively, the interval between roll-off
episodes was also different: between 25 and 35 s in Case 3 and between 25 s and 40 s in
Case 4, in which roll-offs were less frequent. These longer differences imply fewer roll-
off episodes in 12 minutes. The transverse diameters of the coagulation zone for
were 2.84 cm and 2.50 cm for the Cases 3 and 4 respectively.
The case with Qp term set to zero would correspond with a RF ablation with total
cessation in blood flow such as that found during Pringle maneuver. We conducted this
additional simulation and the results showed a diameter of 4.20 cm for =1 and 3.55
cm for =4.6, i.e. larger than in cases 1 and 2, as it is expected.
Experimental results
Figure 7 shows the four lesions created in each hepatic lobe in a representative case. In
the first (A), in which EP only was performed, no coagulation “white area” can be
observed, but only a two 2-mm wide hyperemia along the electrode path. In the second
lobe, in which RFA alone was performed, a “white area” of between 4.8 cm (maximum
diameter) and 1.7 mm (minimum diameter) can be seen. In the third and fourth lobes
(EP+RF procedure) a similar coagulation “white area” between 4.2 cm (maximum
diameter) and 1.6 mm (minimum diameter) were visible. No significant differences
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between EP and RF+EP groups were observed either in the maximum or in the
minimum diameter (Table II).
Discussion
This feasibility study was undertaken to assess whether the reduced blood perfusion
caused by EP pulses applied prior to RFA would significantly reduce the thermal sink
effect and hence increase coagulation volume to a greater extent than that created solely
by RFA. We first conducted a computer modeling study, followed by a brief
experimental study on an in vivo model.
Overall, the results suggest that no synergy effect can be achieved from this hybrid
protocol, i.e. applying EP pulses prior to RFA does not increase the area of the
coagulation zone. The additional computer simulations (Cases 3 and 4) could provide a
possible explanation. In the case of RFA alone (Cases 2 and 4), the fact of not
considering the effect of thermal damage on blood perfusion (Case 4) is responsible for
a reduction of 15% in the transverse diameter as compared to Case 2, in which this
factor was taken into consideration (2.94 cm vs. 2.50 cm). This result agrees with other
previous findings. However, when comparing the two EP+RFA cases (1 and 3), the
transverse diameter decreased by only 4% when blood perfusion was not dependent on
thermal damage (2.98 cm vs. 2.84 cm), which suggests that the effect of EP is
noticeable in Case 3, i.e. only when the reduced blood perfusion due to thermal damage
is not taken into account. In other words, the effect of reducing blood perfusion by
thermal damage completely masks the effect of reducing blood perfusion by EP. This is
due to the fact that both thermal damage and EP affect the tissue next to the electrode.
On one hand the disagreement between experimental and theoretical minor diameters
both in cases EP+RF and RF was due to the different criterion used to assess thermal
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damage. Since theoretical modeling used the Arrhenius damage model (with
probabilities of cell death of 63% and 99%), it is possible that the computed boundaries
do not match very well to the boundaries assessed macroscopically by the “white zone”.
On the other hand, in the computation of Ω we used parameters A and ΔE. The values of
these parameters are obtained experimentally. Bibliography provides several values for
A and ΔE depending on the experiment used to obtained them and they are very
different, see for example [33]. We checked that changes in the A value produced great
differences in lesion dimensions. Then, we chose A and ΔE values which provided
reasonable results, i.e. lesion dimensions in an acceptable range. However, due to the
way in which A and ΔE are obtained and the great influence of A in the value of Ω was 
almost impossible that in our study theoretical predicted lesions were equal to
experimental ones. In spite of this disagreement, the objective of the experiments was
not to validate the theoretical model, but to confirm the results obtained from computer
simulations.
The RF ablation uses a frequency around 500 kHz. Probably over 2 MHz the
displacement currents could take a role more and more important, but in the
electrosurgical range (300 kHz-1MHz), they can be considered negligible.
Several limitations implicit in this study should be pointed out: 1) the theoretical
model only considered the effect of EP on the reduction in blood perfusion, i.e. no late
cytophatic effects (apoptosis) were modeled; and, in relation to this, 2) the experimental
model did not consider the late effects since the coagulation zones were assessed
immediately after the procedure. In spite of these limitations, we think that the effect of
EP on reducing blood perfusion, at least with the monopolar arrangement tested here, is
confined to the vicinity of the electrode, where the heating is mainly concentrated and
the effect on blood perfusion is thus reduced. The impact of the EP pulses in terms of
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reducing blood perfusion is therefore masked by the subsequent RFA, which also has
the effect of reducing blood flow.
On the other hand, one of the main limitations for thermal therapies is the heat sink
by high rate in major blood vessels, which may locally impede the thermal damage to
the tumor, permitting neoplastic cell survival near these blood vessels. To date, the
vascular effects from EP have not been shown to disrupt blood perfusion through these
large vessels. For this reason, the conclusions of our study should be only considered in
the case of combined EP+RFA therapy for tumors not adjacent to large vessels.
Conclusion
As far as we know, no previous studies have been conducted to check the possibility of
combining RFA and EP to increase the size of the coagulation zones when ablating
tumors. Our computer modeling and in vivo experimental findings suggest that this
combination, when using monopolar applicators, does not provide an additional
advantage as compared to the use of RFA alone.
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Table I. Characteristics of the materials used in the theoretical model [11,14].
Tissue/material  (S/m) k (W/m·K) (kg/m3) c (J/kg·K)
Electrode 7.4×106 15 8×103 480
Plastic 10-5 0.026 70 1045
1080(3) 3455(3)
Liver 0.132(1) 0.502(2)
370(4) 2156(4)
electric conductivity; k, thermal conductivity; density; c, specific heat
(1) Assessed at 17ºC (initial temperature). This allows initial impedance (≈100  to be
matched to the mean value experimentally measured in a previous study.
(2) Assessed at 37ºC.
(3) Normal tissue (liquid phase).
(4) Gas phase tissue.
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Table II. Minor diameter of experimental and theoretical lesions (in cm) created in liver
after 720 s of alone RF ablation (RF), and after 720 s of RF ablation combined with
previous electroporation (EP+RF). Two thermal damage contours (and
were used the theoretical case. Not significant differences between EP and
RF+EP groups were observed neither in the maximum nor in the minimum diameter.
EP+RF RF
Theoretical lesion diameter ( 2.98 cm 2.94 cm
Theoretical lesion diameter ( 2.66 cm 2.63 cm
Experimental lesion diameter
(mean ± standard deviation)
2.0 ± 0.30 cm
(n=3)
1.7 ± 0.30 cm
(n=6)
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Figure 1 Geometry of the two-dimensional model used in the theoretical study
(out of scale, dimensions in mm). The domain is divided into three zones:
plastic portion of the electrode, metallic electrode and hepatic tissue.
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Figure 2  Relative blood perfusion after delivery of 8 pulses of 100 μs at 1 Hz. The 
experimental data was obtained from [8]. The model corresponds to
expression (2).
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Figure 3 Distribution of the relative blood perfusion () and the electric field at
the end of the application of the EP pulse.
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Figure 4 Voltage (A) and impedance (B) evolution in the computer simulations of
electroporation + 12-minute RF ablation case without plotting the EP
period. (C) Impedance evolution in the computer simulations of alone RF
ablation.
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Figure 5 Temperature distributions after 12 minutes of RF ablation and previous
application of electroporation pulses. The black lines represent the
thermal damage lesion which corresponds to =1 and =4.6. The values
of the minor transverse lesion diameters (in cm) are shown for both
contours of thermal damage.
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Figure 6 Temperature distributions after 12 minutes of RF ablation and previous
application of EP pulses joint with the blood perfusion level () map.
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Figure 7 Lesions created in hepatic lobes after: electroporation alone (A), RF
ablation alone (B) and electroporation+RF ablation (C and D).
